Bactolac Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.20 M
as on 12-12-2024
- Company Age 43 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.40 M
as on 12-12-2024
- Revenue -34.21%
(FY 2019)
- Profit -191.21%
(FY 2019)
- Ebitda -19.37%
(FY 2019)
- Net Worth -1.32%
(FY 2019)
- Total Assets -9.65%
(FY 2019)
About Bactolac Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹0.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Desani Reddy and Desani Reddy serve as directors at the Company.
- CIN/LLPIN
U24230TG1981PTC003103
- Company No.
003103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 1981
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bactolac Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Desani Reddy  | Managing Director | 25-Jun-1992 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Desani Reddy | Whole-Time Director | 11-Feb-1993 | Current |
Financial Performance of Bactolac Pharmaceuticals.
Bactolac Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 34.21% decrease. The company also saw a substantial fall in profitability, with a 191.21% decrease in profit. The company's net worth dipped by a decrease of 1.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bactolac Pharmaceuticals?
In 2019, Bactolac Pharmaceuticals had a promoter holding of 60.08% and a public holding of 39.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 27 Jun 2003 | ₹0.40 M | Satisfied |
How Many Employees Work at Bactolac Pharmaceuticals?
Unlock and access historical data on people associated with Bactolac Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bactolac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bactolac Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
